| propafenone / Generic mfg. |
NCT00408200: A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation |
|
|
| Completed | N/A | 110 | US | propafenone; flecainide; sotalol; dofetilide, Radiofrequency catheter ablation | University of Pennsylvania | Atrial Fibrillation | 04/08 | 06/08 | | |
NCT00933634: Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation |
|
|
| Completed | N/A | 247 | Europe | electrical cardioversion, propafenone | Valduce Hospital | Atrial Fibrillation | 11/08 | 11/08 | | |
NCT01991119: Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation |
|
|
| Completed | N/A | 98 | RoW | Propafenone, Dronedarone | Samsung Medical Center | Atrial Fibrillation | 10/13 | 10/13 | | |
NCT01775891: Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation |
|
|
| Unknown status | N/A | 245 | RoW | pilsicainide, Pilsicainide (Sunrhythm®) Daiichi Sankyo, other class IC antiarrhythmic drug, flecainide 100mg bid PO or propafenone 225mg tid | Korea University | Paroxysmal Atrial Fibrillation | 07/15 | 07/15 | | |
| Unknown status | N/A | 152 | Europe | Catheterablation, Amiodarone, Cordarone®, Sotalol, Sotalol®, Flecainide, Tambocor®, Propafenone, Rythmol®, Disopyramide, Norpace®, Dronedarone, Multaq® | Uppsala University Hospital, Swedish Heart Lung Foundation | Atrial Fibrillation, Quality of Life | 09/18 | 09/18 | | |
AVATAR-AF, NCT02459574: Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation |
|
|
| Completed | N/A | 300 | Europe | AVATAR-AF ablation, Ablation method-surgical, Anti-Arrhythmic therapy, Amiodarone, Dronaderone, Sotalol, Beta blockers, Calcium channel blockers, Flecainide, Propafenone, Conventional AF ablation | Imperial College London | Heart Failure, Recurrent Atrial Fibrillation | 09/18 | 11/18 | | |
NCT03561935: Beta-blocker vs. Ic Antiarrhythmic Drug for PVC |
|
|
| Withdrawn | N/A | 350 | RoW | Propafenone, Indenol | Yong Seog Oh | Premature Ventricular Complex | 06/19 | 11/19 | | |
NCT02633774: Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation |
|
|
| Unknown status | N/A | 200 | RoW | Propafenone, Apixaban | Yonsei University | Persistent Atrial Fibrillation | 11/20 | 11/20 | | |
NCT03674658: Propafenone in the Treatment of Atrial Fibrillation |
|
|
| Completed | N/A | 71 | RoW | Propafenone, A drug: Rhynorm, B drug: Rytmonorm | TSH Biopharm Corporation Limited | Atrial Fibrillation | 08/21 | 08/21 | | |
| Active, not recruiting | N/A | 303 | Canada | Cryoballoon-based PVI, Anti-Arrhythmic Drug Therapy, sotalol, flecainide, propafenone, dronedarone | Jason Andrade, Ottawa Heart Institute Research Corporation, Medtronic, Baylis Medical Company | Atrial Fibrillation | 09/22 | 11/22 | | |
| Recruiting | N/A | 286 | RoW | Antiarrhythmic drug including Propafenone, Sotalol, Dronedarone and Amiodarone, cryoballoon ablation | Ruijin Hospital | Atrial Fibrillation, Persistent, Arrhythmias, Cardiac | 07/25 | 01/26 | | |
AVANT GUARD, NCT06096337: Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation |
|
|
| Recruiting | N/A | 387 | Europe, Canada, US, RoW | FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, and Dofetilide | Boston Scientific Corporation | Persistent Atrial Fibrillation | 12/25 | 12/27 | | |
